The first two Medical Objectives (MOs) of the project are to better understand frailty and its relation to co-morbidities (MO1) and develop quantitative and qualitative measures to define frailty (MO2).
The third Medical Objective of the project concerns the use of measures developed in order to predict the short and long-term outcome (MO3).
